COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Article uri icon

Overview

authors

  • Roeker, Lindsey E
  • Eyre, Toby A
  • Thompson, Meghan C
  • Lamanna, Nicole
  • Coltoff, Alexander R
  • Davids, Matthew S
  • Baker, Peter O
  • Leslie, Lori
  • Rogers, Kerry A
  • Allan, John
  • Cordoba, Raul
  • Lopez-Garcia, Alberto
  • Antic, Darko
  • Pagel, John M
  • Martinez-Calle, Nicolas
  • García-Marco, José Antonio
  • Hernández-Rivas, Jose-Ángel
  • Miras, Fatima
  • Coombs, Catherine C
  • Österborg, Anders
  • Hansson, Lotta
  • Seddon, Amanda N
  • López Jiménez, Javier
  • Wilson, Matthew R
  • El-Sharkawi, Dima
  • Wojenski, Daniel
  • Ma, Shuo
  • Munir, Talha
  • Valenciano, Susana
  • Seymour, Erlene
  • Barr, Paul M
  • Pu, Jeffrey
  • Patten, Piers E M
  • Perini, Guilherme F
  • Huntington, Scott F
  • Parry, Helen
  • Sundaram, Suchitra
  • Skarbnik, Alan
  • Kamdar, Manali
  • Jacobs, Ryan
  • Walter, Harriet
  • Walewska, Renata
  • Broom, Angus
  • Lebowitz, Sonia
  • Isaac, Krista M
  • Portell, Craig A
  • Ahn, Inhye E
  • Ujjani, Chaitra S
  • Shadman, Mazyar
  • Skånland, Sigrid S
  • Chong, Elise A
  • Mato, Anthony R

publication date

  • November 4, 2021

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Antiviral Agents
  • COVID-19
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • SARS-CoV-2

Identity

PubMed Central ID

  • PMC8313815

Scopus Document Identifier

  • 85119469815

Digital Object Identifier (DOI)

  • 10.1182/blood.2021011841

PubMed ID

  • 34297826

Additional Document Info

volume

  • 138

issue

  • 18